| RNGTT |
RNGTT, CAP1A: mRNA-capping enzyme |
ARHGAP9 |
IPI00442053 |
0.39 |
Evidence |
|
| CHEK1 |
CHEK1, CHK1: Serine/threonine-protein kinase Chk1 |
SNX7 |
SNX7: Sorting nexin-7 |
0.39 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
PLS1 |
PLS1: Plastin-1 |
0.39 |
Evidence |
|
| PDLIM5 |
PDLIM5, ENH: PDZ and LIM domain protein 5 |
TAOK3 |
TAOK3, DPK, JIK, KDS, MAP3K18: Serine/threonine-protein kinase TAO3 |
0.39 |
Evidence |
|
| GTF2B |
GTF2B, TF2B, TFIIB: Transcription initiation factor IIB |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
0.39 |
Evidence |
|
| ACTB |
ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 |
CAMK1 |
CAMK1: Calcium/calmodulin-dependent protein kinase type 1 |
0.39 |
Evidence |
|
| SERPINB1 |
SERPINB1, ELANH2, MNEI, PI2: Leukocyte elastase inhibitor |
SERPINB13 |
SERPINB13, PI13: Serpin B13 |
0.39 |
Evidence |
|
| CA2 |
CA2: Carbonic anhydrase 2 |
SCYL3 |
SCYL3, PACE1: Protein-associating with the carboxyl-terminal domain of ezrin |
0.39 |
Evidence |
|
| NFAM1 |
NFAM1, CNAIP: NFAT activation molecule 1 precursor |
SPON1 |
SPON1, KIAA0762, VSGP: Spondin-1 precursor |
0.39 |
Evidence |
|
| LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
GUCA1C |
GUCA1C, GCAP3: Guanylyl cyclase-activating protein 3 |
0.39 |
Evidence |
|
| PSG7 |
PSG7: Pregnancy-specific beta-1-glycoprotein 7 precursor |
CYSLTR1 |
CYSLT1, CYSLTR1: Cysteinyl leukotriene receptor 1 |
0.39 |
Evidence |
|
| DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
OSBPL6 |
OSBPL6, ORP6: Oxysterol-binding protein-related protein 6 |
0.39 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
PARD6G |
PARD6G, PAR6G: Partitioning defective 6 homolog gamma |
0.39 |
Evidence |
|
| CALML3 |
CALML3: Calmodulin-like protein 3 |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
0.39 |
Evidence |
|
| RB1 |
RB1: Retinoblastoma-associated protein |
BIRC3 |
BIRC3, API2, IAP1, MIHC, RNF49: Baculoviral IAP repeat-containing protein 3 |
0.39 |
Evidence |
|
| RGS12 |
RGS12: Regulator of G-protein signaling 12 |
AXIN2 |
AXIN2: Axin-2 |
0.39 |
Evidence |
|
| RGS12 |
RGS12: Regulator of G-protein signaling 12 |
RGS18 |
RGS18, RGS13: Regulator of G-protein signaling 18 |
0.39 |
Evidence |
|
| RGS12 |
RGS12: Regulator of G-protein signaling 12 |
RGS4 |
RGS4: Regulator of G-protein signaling 4 |
0.39 |
Evidence |
|
| RGS12 |
RGS12: Regulator of G-protein signaling 12 |
RGS5 |
RGS5: Regulator of G-protein signaling 5 |
0.39 |
Evidence |
|
| RGS12 |
RGS12: Regulator of G-protein signaling 12 |
RGS16 |
RGS16, RGSR: Regulator of G-protein signaling 16 |
0.39 |
Evidence |
|
| FA2H |
FA2H: Fatty acid 2-hydroxylase. |
DULLARD |
DULLARD: Serine/threonine-protein phosphatase dullard |
0.39 |
Evidence |
|
| SUPT16H |
SUPT16H, FACT140, FACTP140: FACT complex subunit SPT16 |
TNRC9 |
TOX3, CAGF9, TNRC9: TOX high mobility group box family member 3 |
0.39 |
Evidence |
|
| SLC30A1 |
SLC30A1, ZNT1: Zinc transporter 1 |
TMEM63A |
TMEM63A, KIAA0792: Transmembrane protein 63A |
0.39 |
Evidence |
|
| RABAC1 |
RABAC1, PRA1, PRAF1: Prenylated Rab acceptor protein 1 |
ELOVL6 |
ELOVL6: Elongation of very long chain fatty acids protein 6 |
0.39 |
Evidence |
|
| BIN3 |
BIN3: Bridging integrator 3 |
EVI5 |
EVI5, NB4S: Ecotropic viral integration site 5 protein homolog |
0.39 |
Evidence |
|
- 
- 
-